Erythropoietin inhibits osteoblast function in myelodysplastic syndromes via the canonical Wnt pathway

The effects of erythropoietin on osteoblasts and bone formation are controversial. Since patients with myelodysplastic syndromes often display excessively high erythropoietin levels, we aimed to analyze the effect of erythropoietin on osteoblast function in myelodysplastic syndromes and define the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Balaian, Ekaterina, Wobus, Manja, Weidner, Heike, Baschant, Ulrike, Stiehler, Maik, Ehninger, Gerhard, Bornhäuser, Martin, Hofbauer, Lorenz C, Rauner, Martina, Platzbecker, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777191/
https://www.ncbi.nlm.nih.gov/pubmed/29079596
http://dx.doi.org/10.3324/haematol.2017.172726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777191/
https://www.ncbi.nlm.nih.gov/pubmed/29079596
http://dx.doi.org/10.3324/haematol.2017.172726

Ejemplares similares